| Application no. and date | 93912155.4 (espacenet) (Federated) (European Patent Register), 19930409 | | Patent/reg. no. and date | DK/EP 0641218, 20031217 | | Publication date | 19950308 | | Priority no. and date | US 866827, 19920410, US 981196, 19921125 | | EP pub. no. and date |
EP 0641218 19950308 | | Effective date | | | Applicant/owner | THE BRIGHAM AND WOMEN'S HOSPITAL, INC., 75 Francis Street
Boston, MA 02115, US | | Applicant ref. no. | 117450 | | Inventor | PFEFFER, Marc, A., 1110 West Roxbury Parkway
Chestnut Hill, MA 02167, US,
PFEFFER, Janice, M., 1110 West Roxbury Parkway
Chestnut Hill, MA 02167, US,
Braunwald, Eugene, 75 Scotch Pine Road
Weston, MA 02193, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 45/06 (2006.01) , A61P 9/10 (2006.01) | | Title | Anvendelse af angiotensinantagonist (AT1) til formindskelse af postmyocardial infarktmorbiditet og -mortalitet | | Int. application no. | US1993003318 | | Int. publication no. | WO1993020839 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
